We are proud to announce our collaborative project, formed by @Stream_Bio and @Chelsea_Tech, to develop an innovative rapid diagnostic platform for a range of targets, including #COVID19! 🌟 Read about the joint venture and our pioneering technology here: brightlinedx.com/news/

We are Brightline Dx, a venture proudly developing a novel approach to #RapidDiagnostics, with exciting work ongoing in #healthcare, #COVID19 testing and more 🚀 Follow the link to learn more about our technology and mission: brightlinedx.com/#about

A new discovery could advance #LymeDisease #diagnostics and treatment!

Scientists from @virginia_tech have discovered a unique bacterial property, which is a potential target for treating and diagnosing Lyme disease 👏 Read on: technologynetworks.com/diagn…

Our novel #diagnostic platform, Claritas, has potential applications in numerous fields, including #healthcare, rapid #COVID19 testing, #environmental monitoring 🏥🦠💧 Find out more about our technology here: brightlinedx.com/#claritas

This #ThrowbackThursday we’re looking back at one of our recent @ChemistryWorld articles in the #Chemistry40 supplement! Within, we discussed the need for improved #RapidDiagnostics, and how Brightline DX approached the challenge 🔬 Check it out: chemistryworld.com/chemistry…

Brightline DX takes great pride in being a member of @BIVDA, and supporting the fantastic work performed by our fellow members.

Follow the link below to learn more about this #diagnostic innovation ⤵️

Researchers from @OICR_news have revealed a catalogue of 166 prognostic #cancer biomarkers! 🌟

These biomarkers could improve the forecasting of patient outcomes to enhance treatment strategies. Read on in @Tech_Networks: technologynetworks.com/diagn…

Are you interested in learning more about the applications of our rapid #diagnostic platform?

We’d be happy to discuss our technology and opportunities for collaboration 🤝 Get in touch with us here: brightlinedx.com/contact/

Check out this #LateralFlow time-lapse from our founding partner, @Stream_Bio! This impressively fluorescent #nanotechnology contributes to the sensitivity of our #diagnostic platform. Watch it in action below ⤵️

Researchers from @MethodistHosp have developed a model that could identify individuals who will benefit from #immunotherapy!

By predicting the efficacy of treatment on an individual basis, this model could help to improve patient outcomes 🌟 Read on: technologynetworks.com/diagn…

Rapid, reliable and accessible #COVID19 testing remains a priority.

Claritas was designed with these #diagnostic needs in mind ✅ Discover how we’re working to provide a novel point-of-care testing platform here: brightlinedx.com/#covid

Our novel rapid #diagnostic platform features a highly sensitive reader incorporating proven technology from @Chelsea_Tech! 🤩 Discover how Chelsea’s expertise in #environmental monitoring devices can be applied to the life sciences here: chelsea.co.uk/applications/l…

Have you seen our news page? 📰

We want to keep you in the loop with our latest projects, collaborations and successes. Check out what we’ve been up to here: brightlinedx.com/latest-news…

Thanks to the adaptable nature of our #diagnostic technology, we’re excited to explore new opportunities 🤩 From #environmental monitoring applications to different #healthcare targets, discover more about the potential of Claritas here: brightlinedx.com/#claritas

It’s great to read about developments in #diagnostic techniques for rare disorders!

Scientists from @Cambridge_Uni have used whole genome sequencing to detect 31% more cases of rare genetic disorders than standard tests 👏 Read on: technologynetworks.com/diagn…

We are proud to be a member of @BIVDA! 🌟 Our membership enables us to be part of key industry discussions and opens the way for new collaborations to develop our rapid #diagnostic technology. Learn more about BIVDA here: bivda.org.uk/

It’s fascinating to learn how other areas of science can influence medical #diagnostics!

Engineers from @UofT have developed a coating material with applications in #microfluidics, which could enhance ‘lab-on-a-chip’ technology 👏 Read on: technologynetworks.com/diagn…

Detection sensitivity is a vital aspect of point-of-care #COVID19 testing. Our #diagnostic technology enables accurate detection of low viral loads, with similar sensitivity to PCR ✅

Find out more about how Claritas can enhance rapid #CovidTesting here:brightlinedx.com/#covid

It’s great to read about research that could prevent the spread of #superbugs!

Researchers from @UniofNewcastle have developed a new testing method for wastewater to quantify the transmission of #AntimicrobialResistance 💧 Read on: ncl.ac.uk/press/articles/lat…

Our #RapidDiagnostic platform, Claritas, was developed to address the need for point-of-care #COVID19 testing ⏩

Read about the challenges of current #diagnostic methods and how our technology could help in our @ChemistryWorld article: chemistryworld.com/chemistry…

Our #RapidDiagnostic platform unites innovative technology from founding partners @Stream_Bio and @Chelsea_Tech.

Visit our ‘About’ page to discover how we aim to push the boundaries of in vitro #diagnostics ➡️ brightlinedx.com/#about